We must #UniteToFight.
The COVID-19 pandemic is having a catastrophic impact on the most vulnerable communities around the world and threatens to roll-back progress against HIV, TB and malaria. As a global community, we must #UniteToFight them all.
The Global Fund pools the world’s resources to invest strategically in programs to fight HIV, tuberculosis and malaria and strengthen systems for health. Together as a partnership of governments, civil society, technical agencies, the private sector and people affected by the diseases, we're committed to successfully funding our global efforts.
From mobilizing to investing
Our COVID-19 Response
Due to COVID-19’s extraordinary impact on global public health and HIV, TB and malaria, the Global Fund is mobilizing additional resources to support the world's response in low- to middle-income countries.
COVID-19 Response Mechanism
The Global Fund reacted decisively to the emergence of COVID-19 in 2020, quickly making available more than US$1 billion to support countries to respond to the pandemic, adapt their HIV, TB and malaria programs, and reinforce their already overstretched health systems and community-led health networks. We created the COVID-19 Response Mechanism and enabled countries to reallocate existing funds through grant flexibilities and savings to support their COVID-19 responses.
ACT-Accelerator
Another key part of our response has been our role as a founding partner in the Access to COVID-19 Tools (ACT) Accelerator, a groundbreaking coalition of organizations and governments to accelerate development, production and equitable access to COVID-19 tools. As part of the ACT-Accelerator, the Global Fund is a co-convener of both the Diagnostics Pillar (with FIND) and the Health Systems Connector (with the World Bank), and we are a procurement and deployment partner in the Therapeutics Pillar.
Mobilizing more
Global Fund donors have responded generously to the urgent needs in countries with additional resources. However, the Global Fund still urgently needs up to US$10 billion on top of its core funding to continue to support countries in their COVID-19 response. This figure contributes to the overall financing needs of the ACT-Accelerator. Significant further needs for immediate funding include personal protective equipment (PPE), testing, and treatment (including medical oxygen), strengthening systems for health, and support to mitigate the impact on lifesaving HIV, TB and malaria programs.
© UNICEF/UNI150830/Asselin